Follow the people · Insider

RA

Robert Andrade

Insider · Chief Financial Officer · FENC

Robert Andrade files insider transactions with the SEC as a chief financial officer of Fennec Pharmaceuticals (FENC). We hold 1 disclosed purchase or sale filed since 20 August 2010, 1 of them in the last 90 days.

  • Files forFENC
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure31 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 6 February 201831 August 2026Chief Financial Officer · Fennec Pharmaceuticals (FENC)98 Form 4 lines · source: SEC Form 4
  • Filed 18 August 201018 August 2010Na · Adherex Technologies (ADHXF)1 Form 4 line · source: SEC Form 4

Everything they disclosed

99 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.